OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Letter to Albert Bourla, DVM, Ph.D., Chief Executive Officer of Pfizer and Ugur Sahin, M.D., Chief Executive Officer of BioNTech - Sen. Johnson Continues to Press the FDA, Pfizer, BioNTech on Transparency and Politicization of Vaccine Approval Process

Letter

Date: Oct. 8, 2021
Location: Washington, DC
Issues: Health and Health Care
Keyword Search: Vaccine

Only available in PDF format; use source to view.


Source
arrow_upward